MAPT and Alzheimer disease: Isoastilbin (IAB) was used against AD in a mouse model induced by AlCl3 and D-lactose, as well as in PC12 cells induced by L-Glu, and the results showed that it reduced oxidative damage in both models, while also reducing the deposition of Aβ and phosphorylated tau in the brain of mice.